A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Advanced Thyroid Cancer Patients Who Received Target Therapy
Interventions
DRUG

dabrafenib plus trametinib with or without PD-1 antibody

advanced thyroid cancer patients who harbor BRAF V600E mutation

DRUG

entrectinib or larotrectinib with or without anti-PD-1 antibdoy

advanced thyroid cancer patients who harbor NTRK mutation

DRUG

pralsetinib or selpercatinib with or without anti-PD-1 antibdoy

advanced thyroid cancer patients who harbor RET fusion or medullary thyroid carcinoma patients who habor RET mutation.

DRUG

anlotinib or anlotinib plus anti-PD-1 antibody

For patients with medullary carcinoma, if there is no RET gene mutation or RET gene mutation is unknown

DRUG

lenvatinib plus anti-PD-1 antibody

Advanced thyroid cancer patients who don't harbor the above gene mutation or could not afford the cost of precision treatment even with the above gene mutation

DRUG

Other Targets: precise treatment based on the target

Advanced thyroid cancer patients who had other treatment targets not included above

Trial Locations (8)

100000

RECRUITING

Peking union medical college hospital, Beijing

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

Unknown

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

010000

RECRUITING

Caixia Liu, Hohhot

030000

RECRUITING

Shanxi Cancer Hospital, Shanxi

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Shanxi Province Cancer Hospital

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Zhejiang Cancer Hospital

OTHER

collaborator

The Affiliated Hospital of Inner Mongolia Medical University

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Shanghai 6th People's Hospital

OTHER

collaborator

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

collaborator

Shanghai 10th People's Hospital

OTHER

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

The First Affiliated Hospital of Anhui University of Chinese Medicine

OTHER

collaborator

Hunan Provincial People's Hospital

OTHER

collaborator

Dalian Friendship Hospital Affiliated to Dalian Medical University

UNKNOWN

collaborator

The Third Affiliated Hospital of Soochow University

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Liaoning Cancer Hospital & Institute

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

lead

Fudan University

OTHER